Turns a patient's biomarker test data into ranked treatment options with the most likely response.
Consented intake · your records travel with you · nothing moves without your sign-off
GenomOncology provides biomarker-drug matching. It uses the disease profile from a patient's test data to recommend the treatment options judged most likely to produce an effective response. It is for patients and clinicians who want treatment ideas assembled from the best global thinking and matched precisely to the biology of the individual cancer.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how GenomOncology handles billing.
We don't have confirmed insurance details for GenomOncology yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in GenomOncology's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Other providers in similar categories.
Identify the best treatment ideas using the best global thinking, predict best treatment response
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Matches your tumor's biomarkers to the therapies most likely to work for you — mapping your molecular profile to targeted and approved options.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.